Duality Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,417
Closed -$571K 570
2023
Q1
$571K Buy
+8,417
New +$541K 0.06% 385
2022
Q3
Sell
-39,755
Closed -$1.57M 600
2022
Q2
$1.57M Buy
+39,755
New +$2.13M 0.15% 257

Other funds holding EXAS

Duality Advisers's EXAS Position: Q2 2023 in Review

Duality Advisers sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 8,417 shares — an estimated $571K sold.

Duality Advisers first reported a position in EXAS in Q2 2022 and held it in 2 quarters. The position peaked at $1.57M in Q2 2022. 653 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Duality Advisers reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Duality Advisers sold 8,417 Exact Sciences shares in Q2 2023, an estimated $571K.
  • Duality Advisers first reported a position in Exact Sciences in Q2 2022 and held it in 2 quarters.
  • Duality Advisers's Exact Sciences position peaked at $1.57M in Q2 2022.
  • 653 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.